Literature DB >> 30886664

Qualitative exploration of the education and skill needs of community pharmacists in Saskatoon concerning substance use disorder.

Sarah Fatani1, Roy Dobson1, Anas El-Aneed1.   

Abstract

BACKGROUND: Identifying the skills and educational needs of community pharmacists concerning addiction is critical to improving the services provided for people who suffer from addiction disease (PWSAD).
METHODS: Eleven one-to-one semi-structured interviews were conducted with community pharmacists practising in the Saskatoon Health Region, Canada. The interviews were recorded and transcribed verbatim and verified with the participants. Thematic analysis was employed to analyze the transcripts.
RESULTS: Four major themes were identified: 1) effect of the work setting on pharmacists' encounters with PWSAD, 2) pharmacists' knowledge of key aspects of addiction, 3) level of support within the health care system, and 4) educational and training needs.
CONCLUSION: Participants indicated that a lack of knowledge and training were major hindrances to improving the quality of the services provided to people who suffer from addiction disease. Additional practicum experience at the undergraduate level and interprofessional interactive educational sessions at the continuing educational level were key recommendations emerging from the study.

Entities:  

Year:  2019        PMID: 30886664      PMCID: PMC6410432          DOI: 10.1177/1715163518816726

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN: 1715-1635


  35 in total

Review 1.  Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation.

Authors:  A T McLellan; D C Lewis; C P O'Brien; H D Kleber
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

2.  Opioids for managing patients with chronic pain: community pharmacists' perspectives and concerns.

Authors:  B D Greenwald; E J Narcessian
Journal:  J Pain Symptom Manage       Date:  1999-05       Impact factor: 3.612

3.  Training Community-Based Clinicians in Screening and Brief Intervention for Substance Abuse Problems: Translating Evidence into Practice.

Authors:  Richard Saitz; Lisa M. Sullivan; Jeffrey H. Samet
Journal:  Subst Abus       Date:  2000-03       Impact factor: 3.716

Review 4.  From best evidence to best practice: effective implementation of change in patients' care.

Authors:  Richard Grol; Jeremy Grimshaw
Journal:  Lancet       Date:  2003-10-11       Impact factor: 79.321

5.  The educational interaction between physical therapy and occupational therapy students.

Authors:  Kimberly K Cleary; Dana M Howell
Journal:  J Allied Health       Date:  2003

Review 6.  Harm reduction approaches to alcohol use: health promotion, prevention, and treatment.

Authors:  G Alan Marlatt; Katie Witkiewitz
Journal:  Addict Behav       Date:  2002 Nov-Dec       Impact factor: 3.913

7.  Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study).

Authors:  Benedikt Fischer; Jürgen Rehm; Suzanne Brissette; Serge Brochu; Julie Bruneau; Nady El-Guebaly; Lina Noël; Mark Tyndall; Cameron Wild; Phil Mun; Dolly Baliunas
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

8.  Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?

Authors:  D Davis; M A O'Brien; N Freemantle; F M Wolf; P Mazmanian; A Taylor-Vaisey
Journal:  JAMA       Date:  1999-09-01       Impact factor: 56.272

Review 9.  Evaluating the impact of pharmacists in mental health: a systematic review.

Authors:  Patrick R Finley; M Lynn Crismon; A John Rush
Journal:  Pharmacotherapy       Date:  2003-12       Impact factor: 4.705

10.  Substance abuse and pharmacy practice: what the community pharmacist needs to know about drug abuse and dependence.

Authors:  Anthony C Tommasello
Journal:  Harm Reduct J       Date:  2004-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.